依达罗定是5-HT6受体高亲和性拮抗剂，体内外均有较强活性，Ki为0.83 nM，作为治疗与阿尔茨海默病和精神分裂症相关的认知缺陷的增强疗法。
6-Fluoro-1H-indole
1-(6-Fluoro-1H-indol-3-yl)-N,N-dimethylmethanamine
3-Hydroxybenzaldehyde
6-Fluoroindole-3-acetonitrile
3-(2,2,3,3-Tetrafluoropropoxy)benzaldehyde
